Table 1.
Comparison of baseline characteristics between COVID-19 patients with or without complication of arrhythmia.
| Characteristics | without arrhythmia (n = 224) | with arrhythmia (n = 10) | p-value |
|---|---|---|---|
| Age (years) | 57.0 (42.0–67.0) | 69.0 (63.8–77.5) | 0.013 |
| Sex, n (%) | |||
| Male | 121 (54.0) | 8 (80.0) | 0.192 |
| Female | 103 (46.0) | 2 (20.0) | |
| Comorbidities | |||
| Hypertension, n(%) | 50 (22.3) | 3 (30.0) | 0.698 |
| Coronary heart disease, n(%) | 17 (7.6) | 2 (20.0) | 0.190 |
| Diabetes, n(%) | 27 (12.1) | 1 (10.0) | 1.000 |
| Chronic liver diseases, n(%) | 7 (3.1) | 1 (10.0) | 0.299 |
| Chronic lung diseases, n(%) | 18 (8.0) | 2 (20.0) | 0.206 |
| Others, n(%) | 47 (21.0) | 4 (40.0) | 0.231 |
| Disease severity, n(%) | |||
| Mild | 29 (12.9) | 0 | 0.617 |
| Moderate | 106 (47.3) | 1 (10.0) | 0.023 |
| Severe | 53 (23.7) | 1 (10.0) | 0.461 |
| Critical | 36 (16.1) | 8 (80.0) | <0.001 |
| Laboratory findings | |||
| WBC (× 109/L) | 5.3 (4.1–6.6) | 6.3 (3.6–8.8) | 0.590 |
| Neutrophil (× 109/L) | 3.4 (2.6–4.8) | 5.2 (2.5–8.2) | 0.266 |
| Lymphocyte (× 109/L) | 1.1 (0.7–1.6) | 0.6 (0.4–0.9) | 0.002 |
| LDH (U/L) | 195.0 (152.0–279.5) | 425.5 (378.5–564.5) | 0.001 |
| Hemoglobin (g/L) | 129.0 (119.0–143.0) | 135.5 (125.3–144.5) | 0.413 |
| Platelet (g/L) | 203.0 (149.0–252.0) | 146.5 (89.5–201.8) | 0.054 |
| Albumin (g/L) | 37.6 (32.4–41.0) | 31.7 (29.1–35.7) | 0.014 |
| AST (U/L) | 23.0 (16.0–36.0) | 37.2 (25.5–60.0) | 0.035 |
| ALT (U/L) | 22.0 (15.0–37.0) | 21.5 (9.8–33.8) | 0.417 |
| DBIL (μmol/L) | 3.5 (2.5–4.8) | 4.6 (3.5–5.7) | 0.062 |
| IBIL (μmol/L) | 7.4 (5.2–10.3) | 5.6 (4.5–7.4) | 0.256 |
| TBIL (μmol/L) | 11.0 (8.2–15.1) | 5.5 (4.6–8.8) | 0.990 |
| APTT (s) | 34.2 (31.7–37.0) | 10.6 (8.1–15.0) | 0.936 |
| PT (s) | 13.3 (12.5–14.3) | 34.7 (31.2–37.7) | 0.519 |
| D-dimer (μg/ml) | 0.2 (0.1–0.5) | 0.8 (0.2–7.5) | 0.033 |
| Creatinine (μmol/L) | 70.0 (58.0–82.0) | 75.5 (70.0–94.8) | 0.081 |
| CK (U/L) | 55.0 (37.0–84.0) | 196.0 (92.0–331.5) | 0.004 |
| CK-MB (U/L) | 9.0 (6.0–14.0) | 14.0 (8.0–36.0) | 0.090 |
| hs-CRP (mg/L) | 9.4 (1.1–35.7) | 31.4 (25.6–35.9) | 0.134 |
| Procalcitonin (ng/ml) | 0.08 (0.06–0.17) | 0.2 (0.1–0.4) | 0.033 |
| FBG (mmol/L) | 5.5 (4.8–6.9) | 9.5 (6.8–12.0) | <0.001 |
| NTproBNP (pg/mL) | 127.0 (41.6–420.0) | 422.1 (105.5–1218.2) | 0.079 |
Note: Data were number (percentage) or median (interquartile range). Abbreviations: WBC, white blood cells; LDH, lactate dehydrogenase; AST, aspartate aminotransferase; ALT, alanine aminotransferase; TBIL, Total Bilirubin; DBIL, Direct Bilirubin; IBIL, indirect bilirubin; APTT, activated partial thromboplastin time; PT, prothrombin time; CK, creatine kinase; CK-MB, Creatine kinase isoenzyme; hs-CRP, high-sensitivity C-reactive protein; FBG, fasting blood glucose; NTproBNP, N-terminal portion of proBNP.